Lancaster University researchers report a drug developed to treat diabetes shows promise in reversing memory loss associated with Alzheimer's in mouse models of the disease. The drug appears to have a neuroprotective effect, enhancing brain growth factors while reducing amyloid plaques, chronic inflammation and oxidative stress. The drug also slows down the rate of neuron loss.
WUSTL researchers report a poor night's sleep can cause levels of amyloid beta to rise faster than the brain's waste disposal system can remove it. Researchers note frequent sleep disruptions can lead to an increased risk of developing Alzheimer's disease.
Study reveals how the mechanism for storing olfactory memories differs slightly from erasing unnecessary memories. Understanding how the brain gets rid of unimportant memories could help unlock new avenues of research to better understand memory loss in aging, researchers say.
Following a seizure, deltaFosB remains in the hippocampus for an extensive period of time. Researchers believe this may contribute to memory loss and other cognitive deficits.
Alzheimer's risk is increased for those with anosognosia, a condition in which sufferers are unaware they are experiencing memory loss.
Researchers report boosting levels of osteocalcin in the blood may help reverse age related memory loss in mice.
Researchers discover targeting the HDAC2 enzyme, by blocking its interaction with Sp3, resulted in the reversal of memory loss in mice. The findings, published in Cell Reports, may offer a new avenue for treating memory loss in Alzheimer's disease.
A new study from USC finds people often over-estimate how much we will think about, or talk of, happy memories.